Skip to main content

Advertisement

SpringerLink
Log in

Approach to and Management of the Neutrophilic Dermatoses

  • Hospital-based Dermatology (D. Kroshinsky, Section Editor)
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

The neutrophilic dermatoses are a related set of disorders that share common features. These disorders are not directly related to infection and are considered forms of “sterile” neutrophilic inflammation. They can occur with an associated systemic disease or as a primary cutaneous process. Subcorneal pustular dermatosis, Sweet’s syndrome, erythema elevatum diutinum, bowel-associated dermatosis-arthritis syndrome, pyoderma gangrenosum, and neutrophilic eccrine hidradenitis represent the most common of these disorders. This review highlights the salient features of the neutrophilic dermatoses with an emphasis on clinical features, evaluation, and management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wallach D, Vignon-Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol. 2006;55(6):1066–71.

    Article  PubMed  Google Scholar 

  2. Prat L et al. Neutrophilic dermatoses as systemic diseases. Clin Dermatol. 2014;32(3):376–88. A review article that highlights the systemic manifestations of the neutrophilic dermatoses. This manuscript informs clinicians of this often-overlooked aspect of these disorders and facilitates recognition and appropriate management.

    Article  PubMed  Google Scholar 

  3. Reed J, Wilkinson J. Subcorneal pustular dermatosis. Clin Dermatol. 2000;18(3):301–13.

    Article  CAS  PubMed  Google Scholar 

  4. Roger H et al. Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: simultaneous remission of skin and joint involvements with dapsone treatment. Ann Rheum Dis. 1990;49(3):190–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Nagai H, Harada S. Subcorneal pustular dermatosis accompanied by seronegative arthritis. Acta Derm Venereol. 2002;82(4):318–9.

    Article  PubMed  Google Scholar 

  6. Brantley EI, Sheth P. Subcorneal pustular dermatosis in a patient with rheumatoid arthritis and diffuse scleroderma. Dermatol Online J. 2009;15(3):5.

    PubMed  Google Scholar 

  7. Delaporte E et al. Subcorneal pustular dermatosis in a patient with Crohn’s disease. Acta Derm Venereol. 1992;72(4):301–2.

    CAS  PubMed  Google Scholar 

  8. Garcia-Salces I et al. Subcorneal pustular dermatosis with pathergy phenomenon in a patient with Crohn’s disease. J Eur Acad Dermatol Venereol. 2009;23(3):349–50.

    Article  CAS  PubMed  Google Scholar 

  9. Saulsbury FT, Kesler RW. Subcorneal pustular dermatosis and systemic lupus erythematosus. Int J Dermatol. 1984;23(1):63–4.

    Article  CAS  PubMed  Google Scholar 

  10. Tsuruta D, Matsumura-Oura A, Ishii M. Subcorneal pustular dermatosis and Sjogren’s syndrome. Int J Dermatol. 2005;44(11):955–7.

    Article  PubMed  Google Scholar 

  11. Lombart F et al. Subcorneal pustular dermatosis associated with Mycoplasma pneumoniae infection. J Am Acad Dermatol. 2014;71(3):e85–6.

    Article  PubMed  Google Scholar 

  12. Calista D. Subcorneal pustular dermatosis in a patient with AIDS. J Eur Acad Dermatol Venereol. 2003;17(4):478–9.

    Article  PubMed  Google Scholar 

  13. Brown SJ et al. Subcorneal pustular dermatosis in association with chronic lymphocytic leukaemia. Acta Derm Venereol. 2003;83(4):306–7.

    Article  PubMed  Google Scholar 

  14. Sauder MB, Glassman SJ. Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis. Int J Dermatol. 2013;52(5):624–8.

    Article  CAS  PubMed  Google Scholar 

  15. Ahmad K, Ramsay B. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma. Clin Exp Dermatol. 2009;34(1):46–8.

    Article  CAS  PubMed  Google Scholar 

  16. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964;76:349–56.

    Article  CAS  PubMed  Google Scholar 

  17. Cohen PR, Kurzrock R. Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol. 2000;18(3):265–82.

    Article  CAS  PubMed  Google Scholar 

  18. Fett DL, Gibson LE, Su WP. Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc. 1995;70(3):234–40.

    Article  CAS  PubMed  Google Scholar 

  19. von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31(4):535–56. quiz 557–60.

    Article  PubMed  Google Scholar 

  20. Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42(10):761–78.

    Article  PubMed  Google Scholar 

  21. Wallach D, Vignon-Pennamen MD. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses. Br J Dermatol. 2015. A concise review article that summarizes the salient features of the two most common and well recognized neutrophilic dermatoses, Sweet’s syndrome and pyoderma gangrenosum. This manuscript summarizes our most current understanding of these disorders and concludes with a discussion on genetic mechanisms of disease development as well as the possible overlap with autoinflammatory syndromes.

  22. Clemmensen OJ et al. Acute febrile neutrophilic dermatosis—a marker of malignancy? Acta Derm Venereol. 1989;69(1):52–8.

    CAS  PubMed  Google Scholar 

  23. Yi S, Bhate C, Schwartz RA. Sweet’s syndrome: an update and review. G Ital Dermatol Venereol. 2009;144(5):603–12.

    CAS  PubMed  Google Scholar 

  24. Galaria NA et al. Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited. J Am Acad Dermatol. 2000;43(5 Pt 1):870–4.

    Article  CAS  PubMed  Google Scholar 

  25. DiCaudo DJ, Connolly SM. Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands: a report of 7 cases and review of the literature. Arch Dermatol. 2002;138(3):361–5.

    Article  PubMed  Google Scholar 

  26. Kroshinsky D, Alloo A, Rothschild B, Cummins J, Tan J, Montecino R, et al. Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis. J Am Acad Dermatol. 2012;67(5):945–54.

  27. Malone JC et al. Vascular inflammation (vasculitis) in sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. Arch Dermatol. 2002;138(3):345–9.

    Article  PubMed  Google Scholar 

  28. Cohen PR. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis: an oxymoron or an epiphenomenon? Arch Dermatol. 2002;138(3):400–3.

    Article  PubMed  Google Scholar 

  29. Cohen PR. Subcutaneous Sweet’s syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol. 2005;52(5):927–8.

    Article  PubMed  Google Scholar 

  30. Nobeyama Y, Nakagawa H. Subcutaneous Sweet’s syndrome and neutrophilic panniculitis. J Dermatol. 2014;41(9):861–2.

    Article  PubMed  Google Scholar 

  31. Requena L et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141(7):834–42.

    Article  PubMed  Google Scholar 

  32. Chow S et al. Histiocytoid neutrophilic dermatoses and panniculitides: variations on a theme. Am J Dermatopathol. 2007;29(4):334–41.

    Article  PubMed  Google Scholar 

  33. Liu CI et al. Sweet syndrome with histiocytoid infiltrate and neutropenia: a rare combination. J Am Acad Dermatol. 2009;61(5):882–4.

    Article  PubMed  Google Scholar 

  34. Su WP, Liu HN. Diagnostic criteria for Sweet’s syndrome. Cutis. 1986;37(3):167–74.

    CAS  PubMed  Google Scholar 

  35. Kemmett D, Hunter JA. Sweet’s syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990;23(3 Pt 1):503–7.

    Article  CAS  PubMed  Google Scholar 

  36. Chan HL, Lee YS, Kuo TT. Sweet’s syndrome: clinicopathologic study of eleven cases. Int J Dermatol. 1994;33(6):425–32.

    Article  CAS  PubMed  Google Scholar 

  37. Reuss-Borst MA et al. Sweet’s syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol. 1993;84(2):356–8.

    Article  CAS  PubMed  Google Scholar 

  38. Kawakami T et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004;140(5):570–4.

    Article  CAS  PubMed  Google Scholar 

  39. Piette WW et al. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol. 1994;30(2 Pt 2):293–7.

    Article  CAS  PubMed  Google Scholar 

  40. Cox NH, O’Brien HA. Sweet’s syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol. 1994;19(1):51–2.

    Article  CAS  PubMed  Google Scholar 

  41. Gyorfy A et al. Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol. 2003;40(2):135–6.

    Article  PubMed  Google Scholar 

  42. Khan Durani B, Jappe U. Drug-induced Sweet’s syndrome in acne caused by different tetracyclines: case report and review of the literature. Br J Dermatol. 2002;147(3):558–62.

    Article  CAS  PubMed  Google Scholar 

  43. Thibault MJ, Billick RC, Srolovitz H. Minocycline-induced Sweet’s syndrome. J Am Acad Dermatol. 1992;27(5 Pt 2):801–4.

    Article  CAS  PubMed  Google Scholar 

  44. Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34(5 Pt 2):918–23.

    Article  CAS  PubMed  Google Scholar 

  45. Garty BZ et al. Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib. Pediatrics. 1996;97(3):401–3.

    CAS  PubMed  Google Scholar 

  46. Ayirookuzhi SJ et al. Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia. Arch Dermatol. 2005;141(3):368–70.

    Article  PubMed  Google Scholar 

  47. Hospach T, von den Driesch P, Dannecker GE. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) in childhood and adolescence: two new patients and review of the literature on associated diseases. Eur J Pediatr. 2009;168(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  48. Webb K et al. A review and proposed approach to the neutrophilic dermatoses of childhood. Pediatr Dermatol. 2015;32(4):437–46.

    Article  PubMed  Google Scholar 

  49. Gibson LE, El-Azhary RA. Erythema elevatum diutinum. Clin Dermatol. 2000;18(3):295–9.

    Article  CAS  PubMed  Google Scholar 

  50. Dronda F et al. Erythema elevatum diutinum in human immunodeficiency virus-infected patients—report of a case and review of the literature. Clin Exp Dermatol. 1996;21(3):222–5.

    Article  CAS  PubMed  Google Scholar 

  51. Mitamura Y et al. Nodular scleritis and panuveitis with erythema elevatum diutinum. Am J Ophthalmol. 2004;137(2):368–70.

    Article  PubMed  Google Scholar 

  52. Aldave AJ et al. Peripheral keratitis associated with erythema elevatum diutinum. Am J Ophthalmol. 2003;135(3):389–90.

    Article  PubMed  Google Scholar 

  53. Jiao T, Wang M, Zhu X. A case of erythema elevatum diutinum associated with peripheral ulcerative keratitis. Australas J Dermatol. 2012;53(1):78–80.

    Article  PubMed  Google Scholar 

  54. Momen SE, Jorizzo J, Al-Niaimi F. Erythema elevatum diutinum: a review of presentation and treatment. J Eur Acad Dermatol Venereol. 2014;28(12):1594–602.

    Article  CAS  PubMed  Google Scholar 

  55. Ayoub N et al. Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum. Arch Dermatol. 2004;140(8):931–6.

    Article  CAS  PubMed  Google Scholar 

  56. LeBoit PE, Yen TS, Wintroub B. The evolution of lesions in erythema elevatum diutinum. Am J Dermatopathol. 1986;8(5):392–402.

    Article  CAS  PubMed  Google Scholar 

  57. Jorizzo JL et al. Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Intern Med. 1983;143(3):457–61.

    Article  CAS  PubMed  Google Scholar 

  58. Ely PH. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol. 1980;2(6):473–87.

    Article  CAS  PubMed  Google Scholar 

  59. Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002;20(3):409–19.

    Article  PubMed  Google Scholar 

  60. Jorizzo JL et al. Bowel-associated dermatosis-arthritis syndrome. Immune complex-mediated vessel damage and increased neutrophil migration. Arch Intern Med. 1984;144(4):738–40.

    Article  CAS  PubMed  Google Scholar 

  61. Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol. 2011;52(1):e5–7.

    Article  PubMed  Google Scholar 

  62. Bennett ML et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79(1):37–46.

    Article  CAS  Google Scholar 

  63. Ruocco E et al. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009;23(9):1008–17.

    Article  CAS  PubMed  Google Scholar 

  64. Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191–211. A recent, comprehensive review of pyoderma gangrenosum, from etiopathogenesis to diagnosis and management.

    Article  PubMed  Google Scholar 

  65. Su WP et al. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790–800.

    Article  PubMed  Google Scholar 

  66. Binus AM et al. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244–50.

    Article  CAS  PubMed  Google Scholar 

  67. Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33(4):787–802. vi.

    Article  PubMed  Google Scholar 

  68. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol. 1972;106(6):901–5.

    Article  CAS  PubMed  Google Scholar 

  69. Wilson-Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol. 1988;18(3):511–21.

    Article  CAS  PubMed  Google Scholar 

  70. Braswell, S.F., T.C. Kostopoulos, and A.G. Ortega-Loayza, Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol, 2015.

  71. Su WP et al. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol. 1986;13(5):323–30.

    Article  CAS  PubMed  Google Scholar 

  72. Weenig RH et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002;347(18):1412–8.

    Article  PubMed  Google Scholar 

  73. Powell FC et al. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55(217):173–86.

    CAS  PubMed  Google Scholar 

  74. Bachmeyer C, Aractingi S. Neutrophilic eccrine hidradenitis. Clin Dermatol. 2000;18(3):319–30.

    Article  CAS  PubMed  Google Scholar 

  75. Smith KJ et al. Neutrophilic eccrine hidradenitis in HIV-infected patients. Armed Forces Retrovirus Research Group. J Am Acad Dermatol. 1990;23(5 Pt 1):945–7.

    Article  CAS  PubMed  Google Scholar 

  76. Cheng S et al. Subcorneal pustular dermatosis: 50 years on. Clin Exp Dermatol. 2008;33(3):229–33.

    Article  CAS  PubMed  Google Scholar 

  77. Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet’s syndrome associated with myeloproliferative disorders. J Am Acad Dermatol. 1983;9(5):751–8.

    Article  CAS  PubMed  Google Scholar 

  78. Rochet NM et al. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69(4):557–64.

    Article  CAS  PubMed  Google Scholar 

  79. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009;10(5):301–12.

    Article  PubMed  Google Scholar 

  80. Schadt CR, Callen JP. Management of neutrophilic dermatoses. Dermatol Ther. 2012;25(2):158–72. A review article discussing therapeutic options for management of the neutrophilic dermatoses that offers an evidence-based approach for treatment selection.

    Article  PubMed  Google Scholar 

  81. Case JD, Smith SZ, Callen JP. The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet’s syndrome. Cutis. 1989;44(2):125–9.

    CAS  PubMed  Google Scholar 

  82. Cohen PR. Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Inamadar AC, Anitha B. HIV-seropositive patient with Sweet’s syndrome and nodular scleritis, showing dramatic response after adding dapsone to systemic corticosteroid therapy. Int J Dermatol. 2008;47(8):836–8.

    Article  PubMed  Google Scholar 

  84. Maillard H et al. Colchicine for Sweet’s syndrome. A study of 20 cases. Br J Dermatol. 1999;140(3):565–6.

    Article  CAS  PubMed  Google Scholar 

  85. Horio T et al. Treatment of acute febrile neutrophilic dermatosis (Sweet’s syndrome) with potassium iodide. Dermatologica. 1980;160(5):341–7.

    Article  CAS  PubMed  Google Scholar 

  86. Walling HW et al. The relationship between neutrophilic dermatosis of the dorsal hands and sweet syndrome: report of 9 cases and comparison to atypical pyoderma gangrenosum. Arch Dermatol. 2006;142(1):57–63.

    Article  PubMed  Google Scholar 

  87. Jeanfils S et al. Indomethacin treatment of eighteen patients with Sweet’s syndrome. J Am Acad Dermatol. 1997;36(3 Pt 1):436–9.

    Article  CAS  PubMed  Google Scholar 

  88. Karamlou K, Gorn AH. Refractory sweet syndrome with autoimmune organizing pneumonia treated with monoclonal antibodies to tumor necrosis factor. J Clin Rheumatol. 2004;10(6):331–5.

    Article  PubMed  Google Scholar 

  89. Yamauchi PS et al. Treatment of recurrent Sweet’s syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol. 2006;54(3 Suppl 2):S122–6.

    Article  PubMed  Google Scholar 

  90. Ambrose NL, Tobin AM, Howard D. Etanercept treatment in Sweet’s syndrome with inflammatory arthritis. J Rheumatol. 2009;36(6):1348–9.

    Article  PubMed  Google Scholar 

  91. Miller J et al. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol. 2010;62(4):646–54.

    Article  CAS  PubMed  Google Scholar 

  92. Kontos AP et al. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum. Int J Dermatol. 2006;45(11):1383–5.

    Article  PubMed  Google Scholar 

  93. Ghislain PD, De Decker I, Lachapelle JM. Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. Br J Dermatol. 2004;150(5):1052–3.

    Article  PubMed  Google Scholar 

  94. von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997;137(6):1000–5.

    Article  PubMed  Google Scholar 

  95. Brooklyn TN et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55(4):505–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Charles CA et al. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series. Int J Dermatol. 2007;46(10):1095–9.

    Article  PubMed  Google Scholar 

  97. Pomerantz RG et al. Adalimumab for treatment of pyoderma gangrenosum. Br J Dermatol. 2007;157(6):1274–5.

    Article  CAS  PubMed  Google Scholar 

  98. Eaton PA, Callen JP. Mycophenolate mofetil as therapy for pyoderma gangrenosum. Arch Dermatol. 2009;145(7):781–5.

    Article  CAS  PubMed  Google Scholar 

  99. Cummins DL et al. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol. 2007;157(6):1235–9.

    Article  CAS  PubMed  Google Scholar 

  100. Fonder MA et al. Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol. 2008;58(2):185–206.

    Article  PubMed  Google Scholar 

  101. Caucanas M et al. Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet’s syndrome: the concept of neutrophilic disease. Int J Dermatol. 2013;52(10):1185–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, VA Boston Healthcare System, Boston, MA, USA

    Drew Kurtzman

  2. Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Drew Kurtzman & Ruth Ann Vleugels

  3. Division of Dermatology, University of Louisville, Louisville, KY, USA

    Jeffrey Callen

Authors
  1. Drew Kurtzman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruth Ann Vleugels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey Callen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Drew Kurtzman.

Ethics declarations

Conflict of Interest

Dr. Drew Kurtzman, Dr. Ruth Ann Vleugels, and Dr. Jeffrey Callen declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Hospital-based Dermatology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kurtzman, D., Vleugels, R.A. & Callen, J. Approach to and Management of the Neutrophilic Dermatoses. Curr Derm Rep 5, 18–29 (2016). https://doi.org/10.1007/s13671-016-0129-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-016-0129-6

Keywords

Search

Navigation